Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Nanogen Pharmaceutical Biotechnology","sponsor":"Nanogen Pharmaceutical Biotechnology","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Translational Health Science and Technology Institute (THSTI) Signs Memorandum of Understanding (MoU) with The Nanogen Pharmaceutical Biotechnology JSC, Vietnam","therapeuticArea":"Infections and Infectious Diseases","highestDevelopmentStatus":"Phase III","country":"VIETNAM","productType":"Vaccine","productStatus":"New Molecular Entity","date":"September 2021","url1":"","url2":"","graph1":"Infections and Infectious Diseases","graph2":"Phase III"}]

    Find Clinical Drug Pipeline Developments & Deals by Nanogen Pharmaceutical Biotechnology

    Menu

    Nanogen Pharmaceutical Biotechnology

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Nanogen Pharmaceutical Biotechnology

              Contact Supplier
              • Deals
              Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
              Post an Enquiry Post an Enquiry
              Flag Vietnam
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Translational Health Science and Technology Institute (THSTI) Signs Memorandum of Understanding (MoU) with The Nanogen Pharmaceutical Biotechnology JSC, Vietnam

              Details:

              THSTI has entered into a research collaboration with Nanogen Pharmaceutical, which is developing a new vaccine for COVID-19 named Nano Covax which is the first Covid-19 vaccine to be approved by Vietnam’s Ministry of Health to conduct clinical trial in Vietnam.

              Lead Product(s): Nanocovax

              Therapeutic Area: Infections and Infectious Diseases Product Name: Nanocovax

              Highest Development Status: Phase III Product Type: Vaccine

              Recipient: The Translational Health Science and Technology Institute

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration September 27, 2021

              ASK
              US
              PHARMACOMPASS
              Upload
              your Pipeline Activity
              Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.
              Temad- We think of world-class quality.
              Post Enquiry
              POST ENQUIRY